BioPharma Dive - Latest News

RNA editing biotech Airna adds $155M in funding

Airna will use the Series B round to launch a Phase 1/2 trial of its lead program for alpha-1 antitrypsin deficiency, a disease targeted by several other firms.

Apr 1, 2025 - 12:00
 0
RNA editing biotech Airna adds $155M in funding

Airna will use the Series B round to launch a Phase 1/2 trial of its lead program for alpha-1 antitrypsin deficiency, a disease targeted by several other firms.

Read More

Tags:

Previous Article

NIO, Li Auto Report EV Sale Results For March 2025

Next Article

Meta inks purchase agreement for 150MW floating PV project in Singapore, continu...

Related Posts

Mallinckrodt, Endo to combine in $7B deal

Mallinckrodt, Endo to combine in $7B deal

Mar 13, 2025  0

Lilly expands US manufacturing build-out with $50B target

Lilly expands US manufacturing build-out with $50B target

Feb 26, 2025  0

HHS begins layoffs in chaotic fashion

HHS begins layoffs in chaotic fashion

Apr 1, 2025  0